The U.K. startup has aims to improve on neurodegenerative therapy by using technology developed in a King’s College laboratory run by Christopher Shaw. Shaw is …

Targeting cells involved in blood vessel formation could prevent the growth of the most common type of brain tumour. A type of highly malignant brain …